Story · Medicine & Biotech
Leqembi pen subcutaneous formulation available in Japan
2 outlets · first reported by CareNet on · latest · 17 hours of coverage · 2 countries
Eisai and Biogen launched LEQEMBI Pen in Japan on November 12, 2026; the subcutaneous formulation was approved on September 16, 2026 and published in the National Health Insurance drug price list. (Longevity.Technology)
Coverage, in order
-
Eisai and Biogen launch subcutaneous lecanemab for self-injection at home在宅で自己注射が可能なレカネマブ皮下注製剤を発売/エーザイ・バイオジェン
Launched in Japan on 13 November 2026.エーザイとバイオジェン・ジャパンは2026年11月13日に、レカネマブ皮下注製剤(商品名:レケンビ皮下注250mgペン)を発売した。適応は「アルツハイマー病による軽度認知障害及び軽度の認知症の進行抑制」である。…
-
Leqembi pen subcutaneous formulation available in Japan
Eisai and Biogen launched LEQEMBI Pen in Japan on November 12, 2026; the subcutaneous formulation was approved on September 16, 2026 and published in the National Health Insurance drug price list.
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.